This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
A10BG
1 out of 7 registries used, show all original rules.
3812
Check minimum number of events
Min. number of events
3
3812
Include endpoints None
3812
Remove individuals based on genotype QC
3692
DPP4INH
Control definitions
Control exclude
DIAB_MED_OTHER
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Dipeptidyl peptidase 4 (DPP-4) inhibitors
based on the number of shared cases.
Broader endpoints:
- Other (not insulin) diabetes medications
- Diabetes medication
- Type 2 diabetes
- Diabetes mellitus
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3692 | 1504 | 2188 |
| Unadjusted prevalence (%) | 0.90 | 0.65 | 1.20 |
| Mean age at first event (years) | 59.81 | 59.07 | 60.32 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: DPP4INH – Dipeptidyl peptidase 4 (DPP-4) inhibitors
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Dipeptidyl peptidase 4 (DPP-4) inhibitors
↥Endpoint not on priority list, no data to show.